FBLG
FibroBiologics, Inc. Common Stock
NASDAQ: FBLG · HEALTHCARE · BIOTECHNOLOGY
$1.32
+0.76% today
Updated 2026-04-30
Market cap
$6.45M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-8.40
Dividend yield
—
52W range
$1 – $23
Volume
1.0M
FibroBiologics, Inc. Common Stock (FBLG) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | — | $468000.00 | $4.82M | $11.82M | $16.45M |
| Cash & equivalents | — | $407000.00 | $2.27M | $9.16M | $13.98M |
| Current assets | — | $468000.00 | $2.63M | $9.21M | $14.23M |
| Total liabilities | — | $1.76M | $8.82M | $10.57M | $13.71M |
| Current liabilities | — | $1.76M | $7.07M | $9.18M | $12.73M |
| Long-term debt | — | — | — | — | — |
| Shareholder equity | — | $-1.29M | $-4.00M | $1.25M | $2.73M |
| Retained earnings | $-1.17M | $-2.75M | $-7.87M | $-24.36M | $-35.52M |
| Accounts receivable | — | — | $300000.00 | — | — |
| Inventory | — | — | — | — | — |
| Goodwill | — | — | — | — | — |